RxDoctor Payments Data

Nikolaos Andreatos, MD

Medical Oncology · Saint Louis, MONPI 1982196499

Payments from drug & device makers

$250,009in general payments, 2019–2025

Across 17 payments — averaging $14,706 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$127K
  • Takeda Pharmaceuticals U.S.A., Inc.$59K
  • AbbVie$41K
  • Ipsen Biopharmaceuticals, Inc$24K

What the payments were for

  • Food & beverage$19100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$250,009 in reported general payments places this provider in the 55th percentile of 144 medical oncology providers in Missouri.

See all medical oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$10,860
Medicare patients
56
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyurea14$266
Dexamethasone13$205
Ondansetron Hcl11$71

Paid to pharmacies, not to this prescriber.

Other medical oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →